NCT00388791已完成4 期
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
Southern California College of Optometry at Marshall B. Ketchum University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2006年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Tear breakup time
研究概览
简要总结
The purpose of this study is to compare the efficacy of Systane Free to Saline in decreasing the symptoms of dry eye after aggressive therapy. As a principal outcome measure, we are using the modified Schein dry eye symptomatology questionaire to determine whether any improvement in signs is mirrored by improvement in the Schein Score. Up to 30 dry eye subjects will be dosed six times per day for one month. The typical clinical signs will be onmitored (e.g., corneal staining) along with dyrness symptoms. The hypothesis is that an optimized drop, Systane Free, will be more effective than saline solution in improving dry eye signs and symptoms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The informed consent document must be read, signed and dated by the subject or legally authorized representative before conducting any procedures. Additionally, the informed consent document must be signed and dated by the individual obtaining consent of the subject.
- •Adult subjects with mild to moderate dry eye. Criteria for the diagnosis must include two of the three following characteristics as demonstrated at the Eligibility Visit:
- •Composite symptom score of greater than or equal to 7 on the Schein Questionnaire.
- •Sodium Fluorescein (NaFl) Tear Break-Up Time less than 7 seconds in both eyes. Cumulative Sodium Fluorescein Corneal Staining greater than or equal to 4 in both eyes on a 0 to 20 point scale.
- •Rose Bengal corneal staining greater than 4 of 24 maximum for 6 zones. Able and willing to follow study instructions. Subjects must have best corrected visual acuity of twenty twenty five or better in each eye.
- •The informed consent document must be read, signed and dated by the subject or legally authorized representative before conducting any procedures. Additionally, the informed consent document must be signed and dated by the individual obtaining consent of the subject.
- •Adult subjects with mild-to-moderate dry eye. Criteria for the diagnosis must include two of the three following characteristics as demonstrated at the Eligibility Visit
- •Composite symptom score of greater than or equal to 7 on the Schein Questionnaire.
- •Sodium FluoresceinTear Break-Up Time less than or equal to 7 seconds in both eyes.
- •Cumulative Sodium Fluorescein Corneal Staining greater than or equal to 4 in both eyes on a 0 to 20 point scale.
- •Rose Bengal corneal staining greater than 4 of 24 maximum for 6 zones. Able and willing to follow study instructions. Subjects must have best corrected visual acuity of twenty twenty five or better in each eye.
排除标准
- •History or evidence of ocular or intraocular surgery in either eye within the past six months. LASIK and other keratorefractive procedure patients may participate if the surgery was earlier than 12 months at the time of the beginning of the study.
- •History or evidence of serious ocular trauma in either eye within the past six months.
- •History of hypersensitivity to any component of the study medications. These include the artificial tear and the diagnostic dye sodium fluorescein.
- •History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia, active or recent varicella, viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye.
- •Use of topical ocular medications during the study period. Subjects using systemic steroids, immunosuppressive agents and/or anti-cholinergics (e.g. cold and allergy medications, tricyclic antidepressants) for treatment of autoimmune connective tissue disease may not be enrolled in the study if they have not been on a stable dosing regimen for a minimum of 30 days prior to the Eligibility Visit. In addition, the dosing regimen must remain stable throughout the 4-week treatment period.
- •Ocular conditions such as active acute conjunctival infections or iritis. Individuals unwilling to discontinue contact lens wear for seven days prior to the study and throughout the study.
- •Participation in an investigational drug or device study within 30 days of entering this study.
结局指标
主要结局
Tear breakup time
Ocular health measures, including corneal staining and rose bengal staining
Symptom scores using the Schein questionnaire
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Comparison of the effects of normal saline versus plasmalyte on acid base balance during living donor kidney transplantation using pulse pressure variatioCTRI/2021/01/030227PGIMER
招募中
3 期
comparing crystaloidsIRCT20181105041562N1Kermanshah University of Medical Sciences1,300
已完成
不适用
Comparison of the clinical results of salt therapy with surgery in treatment of umbilical granuloma in infantsmbilical Granuloma.Other granulomatous disorders of skin and subcutaneous tissueIRCT2016042620663N3Vice chancellor for research, Tabriz University Of Medical Sciences.50
已完成
3 期
Comparision of fluids used during surgery of head injury patientsCTRI/2019/08/020655JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH90
已完成
3 期
Comparison of normal saline with normal saline plus antibiotic in abdominal lavage in secondary peritonitisIRCT2016092529818N1Vice chancellor for research, Baqiyatallah University of Medical Sciences80